Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in HIV-associated Atherosclerosis
NCT03402815Phase 4Completed
- Sponsor
- University of Perugia
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc in atherosclerosis, sponsored by University of Perugia. Started Jan 2015; status: completed.
02
Drugs
maraviroc
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT03402815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402815.